Company profile: HistoSonics
1.1 - Company Overview
Company description
- Provider of non-invasive medical devices and technologies for interventional radiology and surgical robotics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HistoSonics
Enara Bio
HQ: United Kingdom
Website
- Description: Provider of cancer immunotherapy solutions targeting the T-cell/cancer cell interface, offering the EDAPT platform to discover cancer-specific Dark Antigens, TCR-directed immunotherapies, and off-the-shelf therapeutic cancer vaccines targeting multiple Dark Antigens for broad patient populations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enara Bio company profile →
Remix Therapeutics
HQ: United States
Website
- Description: Provider of small-molecule medicines and an RNA-processing drug discovery platform. Offers REMaster to design modulators, supported by machine-learning data science on a transcriptome database, biology and biomolecular sciences with multiplexed HT screening, and medicinal/computational chemistry. Pipeline targets oncology and neurodegeneration, including REM-422, an mRNA degrader targeting MYB for ACC and AML, in Phase 1.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remix Therapeutics company profile →
Shorla Oncology
HQ: Ireland
Website
- Description: Provider of innovative oncology drugs focused on women's and pediatric cancers, developing and commercializing life-saving treatments that address unmet needs. Portfolio includes FDA-approved JYLAMVO (oral methotrexate) and TEPYLUTE for breast and ovarian cancer, as well as a Nelarabine Injection; pipeline programs include SH-201 under FDA review and SH-110 in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Shorla Oncology company profile →
Previse
HQ: United States
Website
- Description: Provider of life sciences diagnostics focused on developing and commercializing diagnostic tests for cancer prevention and early detection, with specialization across diagnostics, medical devices, medicine, and Medtech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Previse company profile →
Aulos Bioscience
HQ: United States
Website
- Description: Provider of cancer immuno-oncology therapeutics, including AU-007, a computationally designed human IgG1 monoclonal antibody that selectively binds to the CD25-binding portion of IL-2 to prevent immune suppression, reduce toxic side effects, and enhance immune activation against solid tumors; plus an AI discovery platform by Biolojic Design using machine learning algorithms to design specific, highly selective functional monoclonal antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aulos Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HistoSonics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HistoSonics
2.2 - Growth funds investing in similar companies to HistoSonics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HistoSonics
4.2 - Public trading comparable groups for HistoSonics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →